Outcome of Board Meeting held on 28th May 2025

Revenue DeclineResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-8.5%Reaction day

₹151.75

prior close

₹143.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-8.8% vs market

Pharmaceuticals peers, median of 147sector+0.5%-9.0% vs sector

On the reaction day the stock moved 8.8 pts less than Nifty Microcap 250 and 9.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.2

10m

-4.2

15m

-3.1

30m

-3.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-8.5+0.4-8.8+0.5-9.0

Next day

-8.9+0.7-9.5-0.2-8.7

-7.2+0.7-8.0-0.3-6.9

-6.6+0.5-7.1-0.4-6.2

-7.7+1.0-8.6-0.1-7.6

-7.8+1.5-9.3-0.1-7.7

-8.1+2.8-10.9+0.5-8.6

15d

-10.4-0.7-9.7-2.8-7.6

-6.4+3.7-10.1+0.2-6.7

-6.6+3.0-9.6+1.4-8.0

-11.0-1.4-9.6-4.0-7.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board approved audited financial results for Q4 and FY ended 31st March 2025. FY25 revenue from operations fell to Rs. 6,547.13 lakhs from Rs. 6,950.97 lakhs in FY24, a decline of about 5.8%. Net profit after tax was marginally higher at Rs. 1,240.73 lakhs vs Rs. 1,224.29 lakhs (up ~1.3%), while EPS rose to Rs. 12.49 from Rs. 11.78. The Board recommended a final dividend of Rs. 3.00 per share (30% on equity capital), subject to shareholder approval. Statutory auditors issued an unmodified (clean) opinion. The Cost Auditor and Internal Auditor were re-appointed for FY 2025-26.

Likely market impact

The dividend declaration is a positive signal for shareholders, and a clean audit opinion reflects no governance red flags. However, the revenue decline in FY25 and a sharper drop in Q4 PAT (from Rs. 210.16 lakhs to Rs. 84.43 lakhs year-on-year) suggest weakening top-line momentum, which investors should watch closely.